UnknownPhase 4ketamine

The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery

Sponsored by Flavia orange

NCT ID
NCT02782429
Target Enrollment
50 participants
Start Date
2016-04

About This Study

The purpose of this study is to analyze the Ketamine with its anti-inflammatory profile would be able to prevent cognitive disorders in the postoperative period of cardiac surgery, since these disorders contribute to an impact on morbidity / mortality in this population.

Conditions Studied

DeliriumInflammationCognitive DisordersAmnesticDementia

Interventions

  • Ketamine
  • Saline

Eligibility

Age:50 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* Patients aged over 50 years.
* Be submitted to cardiac surgery by sternotomy and with the use of cardiopulmonary bypass (CPB).
* American Society of Anesthesiologists classification 1, 2,3 and 4.

Exclusion Criteria:

* Patients undergoing reoperation.
* Patients undergoing heart transplantation.
* Patients using vasopressor agents and / or ionotropic continuous preoperatively.
* Patients with prior endotracheal intubation and consequently Ventilatory Assistance Mechanics.
* Patients with documented psychiatric disorders.
* Patients with previous cognitive disorders.
* Patients with a history of alcohol or drug abuse.
* Patients with a history of cerebrovascular accident (CVA) with less than 3 months.

Study Locations (1)

Instituto de Medicina Integral Prof Fernando Figueira
Recife, Pernambuco, Brazil

This trial is not recruiting

This study is currently not accepting new participants.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source

The Role of Ketamine in Preventing Cognitive Dysfunctions in Postoperative Period of Cardiac Surgery | Huxley